Tag: Glenmark
Glenmark to sell BeiGene’s oncology medicines, Tislelizumab and Zanubrutinib in India
Under this strategic collaboration, Glenmark will be responsible for locally required development, registration and distribution providing access to BeiGene's innovative oncology medicines for cancer patients across India
Glenmark becomes first to launch biosimilar of popular anti‐diabetic drug, Liraglutide,...
Lirafit™ will sharply lower the daily cost of therapy by around 70% to around Rs 100; making the drug more accessible to a larger number of patients with type 2 diabetes mellitus in the country
Glenmark organizes hypertension awareness campaign across India
The company partnered with more than 8000 doctors and 10,000 healthcare professionals from 42 cities across the country; with the target of reaching out to more than 10 crore Indians
Glenmark concludes Hypertension Awareness Month, partners with18,000 HCPs
The company partnered with more than 8000 hospitals and clinics in 50 cities across the country, conducting over 110 Hypertension public awareness rallies and 8000+ Hypertension screening camps
Glenmark receives ‘India Pharma Innovation of the Year’ Award
The prestigious award was conferred upon company by the Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers for multiple patents and commercialized innovations over the last three years
Glenmark Pharma reports revenue growth of 13.9%
For the third quarter of FY 2021-22, Glenmark’s consolidated revenue was at Rs. 31,734 Mn as against Rs. 27,868 Mn recording an increase of 13.9% YoY.
Glenmark’s deal with Harbour BioMed to make it richer by $120...
Glenmark Pharmaceuticals S.A. and Harbour BioMed have entered into an exclusive license agreement for the Greater China territory to develop, manufacture and commercialize GBR 1302, Glenmark's bispecific antibody for cancer...…………..
Glenmark aims to transform the treatment for Psoriasis in India
Launches Apremilast, a revolutionary advanced oral treatment that addresses various limitations of the current therapies available in India................
14th edition of BioAsia concludes, witnesses massive participation & partnerships
With over 1200 trade, partnership, and deliberation meetings, BioAsia 2017 witnessed large scale participation from various stakeholders across India and globe....